Literature DB >> 22348921

The effect of telephonic patient support on treatment for opioid dependence: outcomes at one year follow-up.

Charles Ruetsch1, Joseph Tkacz, Tracy L McPherson, John Cacciola.   

Abstract

OBJECTIVE: The present study examined the impact of a telephonic patient support program known as HereToHelp™ (HTH) on compliance and treatment outcomes among opioid dependent (OD) patients new to buprenorphine treatment (BUP).
METHOD: A total of 1426 OD patients new to BUP were randomized to receive BUP alone (standard care) or BUP plus the HTH patient support program. All patients completed the Addiction Severity Index (ASI) at the time of enrollment, and at 12months post-enrollment.
RESULTS: Subjects randomized to the HTH support program who accepted at least 3 care coach intervention calls were more compliant with BUP than the standard care group at month 12 (64.4% vs. 56.1%, χ(2)=5.09, p<.025). Compared to patients who were non-compliant with BUP, compliant patients reported significantly lower scores on all 7 of the ASI composite scores, indicating lower severity on addiction-related problems.
CONCLUSIONS: The HTH intervention seemed to improve patient treatment outcomes indirectly by improving compliance with BUP. Supplementing BUP with a structured, telephonic compliance-enhancement program is an effective way to improve compliance with medication which then improves patient outcomes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22348921     DOI: 10.1016/j.addbeh.2012.01.013

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  8 in total

Review 1.  Retention in medication-assisted treatment for opiate dependence: A systematic review.

Authors:  Christine Timko; Nicole R Schultz; Michael A Cucciare; Lisa Vittorio; Christina Garrison-Diehn
Journal:  J Addict Dis       Date:  2015-10-14

Review 2.  Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.

Authors:  Brandon D L Marshall; Traci C Green; Jesse L Yedinak; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2016-02-04

3.  When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al.

Authors:  Robert P Schwartz
Journal:  J Addict Med       Date:  2016 Jul-Aug       Impact factor: 3.702

4.  The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine.

Authors:  Declan T Barry; Tera Fazzino; Emily Necrason; Joel Ginn; Lynn E Fiellin; David A Fiellin; Brent A Moore
Journal:  J Addict Med       Date:  2016 Sep-Oct       Impact factor: 3.702

5.  Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.

Authors:  Jessica J Wyse; Benjamin J Morasco; Jacob Dougherty; Beau Edwards; Devan Kansagara; Adam J Gordon; P Todd Korthuis; Anaïs Tuepker; Stephan Lindner; Katherine Mackey; Beth Williams; Anders Herreid-O'Neill; Robin Paynter; Travis I Lovejoy
Journal:  Drug Alcohol Depend       Date:  2021-07-29       Impact factor: 4.852

6.  Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review.

Authors:  Jackson M Steinkamp; Nathaniel Goldblatt; Jacob T Borodovsky; Amy LaVertu; Ian M Kronish; Lisa A Marsch; Zev Schuman-Olivier
Journal:  JMIR Ment Health       Date:  2019-03-12

Review 7.  A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction.

Authors:  Karen Dugosh; Amanda Abraham; Brittany Seymour; Keli McLoyd; Mady Chalk; David Festinger
Journal:  J Addict Med       Date:  2016 Mar-Apr       Impact factor: 3.702

Review 8.  Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review.

Authors:  Brian Chan; Emily Gean; Irina Arkhipova-Jenkins; Jennifer Gilbert; Jennifer Hilgart; Celia Fiordalisi; Kimberly Hubbard; Irene Brandt; Elizabeth Stoeger; Robin Paynter; Philip Todd Korthuis; Jeanne-Marie Guise
Journal:  J Addict Med       Date:  2021 Jan-Feb 01       Impact factor: 4.647

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.